AVITA Medical announced it has entered into a distribution agreement with PolyMedics Innovations GmbH, to strategically expand its global presence to Europe. Under the terms of the agreement, PolyMedics Innovations will serve as the Company’s exclusive distributor of RECELL in Germany, Austria, and Switzerland, with an option to expand to additional European markets in the future. “Our partnership with PolyMedics Innovations represents the first step of our strategic global expansion,” said Jim Corbett, Chief Executive Officer of AVITA Medical. “Their proven track record and expertise in the global distribution of innovative wound treatments make them an ideal partner. We look forward to a successful collaboration that will enable us to reach more patients worldwide.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on RCEL:
- AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year
- AVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to Europe
- Avita Medical Ltd (RCEL) Q3 Earnings Cheat Sheet
- AVITA Medical to Announce Third Quarter 2023 Financial Results
- Avita Medical sees Q3 commercial revenue $13.5M